OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies
Peter Würtz, Antti J. Kangas, Pasi Soininen, et al.
American Journal of Epidemiology (2017) Vol. 186, Iss. 9, pp. 1084-1096
Open Access | Times Cited: 492

Showing 1-25 of 492 citing articles:

NMR Spectroscopy for Metabolomics Research
Abdul‐Hamid Emwas, Raja Roy, Ryan T. McKay, et al.
Metabolites (2019) Vol. 9, Iss. 7, pp. 123-123
Open Access | Times Cited: 868

Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
Michael V. Holmes, Iona Y. Millwood, Christiana Kartsonaki, et al.
Journal of the American College of Cardiology (2018) Vol. 71, Iss. 6, pp. 620-632
Open Access | Times Cited: 392

High‐Throughput Metabolomics by 1D NMR
Alessia Vignoli, Veronica Ghini, Gaia Meoni, et al.
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 4, pp. 968-994
Open Access | Times Cited: 311

A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals
Joris Deelen, Johannes Kettunen, Krista Fischer, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 289

Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
Heli Julkunen, Anna Cichońska, Mika Tiainen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 221

Metabolomic profiles predict individual multidisease outcomes
Thore Buergel, Jakob Steinfeldt, Greg Ruyoga, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2309-2320
Open Access | Times Cited: 218

Quantitative Lipoprotein Subclass and Low Molecular Weight Metabolite Analysis in Human Serum and Plasma by 1H NMR Spectroscopy in a Multilaboratory Trial
Beatriz Jiménez, Elaine Holmes, Clement Heude, et al.
Analytical Chemistry (2018) Vol. 90, Iss. 20, pp. 11962-11971
Open Access | Times Cited: 191

Exome sequencing of Finnish isolates enhances rare-variant association power
Adam E. Locke, Karyn Meltz Steinberg, Charleston W. K. Chiang, et al.
Nature (2019) Vol. 572, Iss. 7769, pp. 323-328
Open Access | Times Cited: 186

Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls
Mariska Bot, Yuri Milaneschi, Tahani Alshehri, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 5, pp. 409-418
Open Access | Times Cited: 182

Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts
Ari Ahola‐Olli, Linda Mustelin, Maria Kalimeri, et al.
Diabetologia (2019) Vol. 62, Iss. 12, pp. 2298-2309
Open Access | Times Cited: 173

Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk
Alexander Kurilshikov, Inge C.L. van den Munckhof, Lianmin Chen, et al.
Circulation Research (2019) Vol. 124, Iss. 12, pp. 1808-1820
Open Access | Times Cited: 163

Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies
Qiao Jin, Ronald C.W.
Cells (2021) Vol. 10, Iss. 11, pp. 2832-2832
Open Access | Times Cited: 159

Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population
Heli Julkunen, Anna Cichońska, P. Eline Slagboom, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 157

VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins
Mie Balling, Shoaib Afzal, Anette Varbo, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 23, pp. 2725-2735
Open Access | Times Cited: 143

Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease
Yeela Talmor‐Barkan, Noam Bar, Aviv A. Shaul, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 295-302
Closed Access | Times Cited: 119

Genome-wide characterization of circulating metabolic biomarkers
Minna K. Karjalainen, Savita Karthikeyan, Clare Oliver‐Williams, et al.
Nature (2024) Vol. 628, Iss. 8006, pp. 130-138
Open Access | Times Cited: 79

Quality control and removal of technical variation of NMR metabolic biomarker data in ~120,000 UK Biobank participants
Scott C. Ritchie, Praveen Surendran, Savita Karthikeyan, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 75

Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study
Fiona Bragg, Eirini Trichia, Diego Aguilar‐Ramirez, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 71

Elevated LDL Triglycerides and Atherosclerotic Risk
Mie Balling, Shoaib Afzal, George Davey Smith, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 2, pp. 136-152
Open Access | Times Cited: 55

NMR Metabolomics Methods for Investigating Disease
G. A. Nagana Gowda, Daniel Raftery
Analytical Chemistry (2023) Vol. 95, Iss. 1, pp. 83-99
Open Access | Times Cited: 41

Data-driven identification of predictive risk biomarkers for subgroups of osteoarthritis using interpretable machine learning
Rikke Linnemann Nielsen, Thomas Monfeuga, Robert R. Kitchen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17

NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects
Eeva Sliz, Sylvain Sebért, Peter Würtz, et al.
Human Molecular Genetics (2018) Vol. 27, Iss. 12, pp. 2214-2223
Open Access | Times Cited: 124

Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study
Caroline J. Bull, Joshua A. Bell, Neil Murphy, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 120

Page 1 - Next Page

Scroll to top